Speech-Language Pathologists in Derby, NY Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Julie Wade Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7821 Erie Rd, Derby, NY 14047 Phone: 724-674-2873

Ms. Sandra Harris Lindstrom, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6745 Erie Rd, Derby, NY 14047 Phone: 716-926-2460    Fax: 716-947-9269

Mrs. Julie M. Farrell, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6745 Erie Rd, Derby, NY 14047 Phone: 716-926-4260    Fax: 716-947-9269

Brittany C Smith, MA SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7821 Erie Rd, Derby, NY 14047 Phone: 716-549-0585

Lynn Gotsch, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6892 Kimberly Ln, Derby, NY 14047 Phone: 716-947-9201

Holly Kathryn Mangus Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7821 Erie Rd, Derby, NY 14047 Phone: 716-549-0585

Shari Lee Bogold-baumann, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6555 Lake Shore Rd, Derby, NY 14047 Phone: 716-912-3061

Jessica Marie Sills Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1375 Elwood Dr, Derby, NY 14047 Phone: 716-947-5690

News Archive

NIHR research program aims to increase safety, well-being of victims of DVA

Researchers at the University of Bristol have received more than £2.5 million from the National Institute for Health Research to carry out research that aims to increase the safety and well-being of victims of domestic violence and abuse (DVA).

Feeding tube use more likely at big, for-profit hospitals

Larger, for-profit hospitals may be using too many feeding tubes on patients with advanced dementia without improving the quality of their care, a study finds, according to HealthDay News/Business Week. "Our results suggest that decisions about feeding tubes are more about which hospital you go to than a decision-making process that really elicits and supports patient choice," said the physician who led the study, which appears in today's Journal of the American Medical Association.

TTF therapy with chemotherapy increases survival time in patients with non-small cell lung cancer

Novocure reported today that patients with advanced non-small cell lung cancer (NSCLC) achieved a significant increase in survival time when tumor treating fields (TTF) therapy was added to chemotherapy, as compared to previously reported outcomes for patients receiving chemotherapy alone.

FDA grants QLT's QLT091001 orphan drug designation for treatment of Retinitis Pigmentosa

QLT Inc. today announced that QLT091001, the Company's oral synthetic retinoid, has been granted orphan drug designation for the treatment of Retinitis Pigmentosa (RP) from the U.S. Food and Drug Administration (FDA). This follows the FDA grant of orphan drug designation for QLT091001 for the treatment of Leber Congenital Amaurosis (LCA) also on December 7, 2010.

Viewpoints: U.S. 'designed for stalemate'; tea party's last stand?; 'war over Obamacare' not over

Though the big social insurance programs are still running, many federal programs that directly target those in the most need are either empty or running on fumes. ... The growth of the modern state is tied to the awareness of public issues in health and the need to address them.

Read more Medical News

› Verified 3 days ago